nodes	percent_of_prediction	percent_of_DWPC	metapath
Bacitracin—IDE—nephron tubule—kidney cancer	0.0571	0.149	CbGeAlD
Bacitracin—IDE—cortex of kidney—kidney cancer	0.0489	0.127	CbGeAlD
Bacitracin—IDE—gonad—kidney cancer	0.0465	0.121	CbGeAlD
Bacitracin—IDE—Alzheimers Disease—MME—kidney cancer	0.0451	0.0899	CbGpPWpGaD
Bacitracin—A2M—nephron tubule—kidney cancer	0.0439	0.114	CbGeAlD
Bacitracin—IDE—Alzheimers Disease—APAF1—kidney cancer	0.0419	0.0836	CbGpPWpGaD
Bacitracin—A2M—HDL-mediated lipid transport—SCARB1—kidney cancer	0.0408	0.0813	CbGpPWpGaD
Bacitracin—A2M—renal system—kidney cancer	0.0399	0.104	CbGeAlD
Bacitracin—A2M—kidney—kidney cancer	0.0386	0.101	CbGeAlD
Bacitracin—IDE—Alzheimers Disease—ITPR2—kidney cancer	0.0379	0.0756	CbGpPWpGaD
Bacitracin—A2M—cortex of kidney—kidney cancer	0.0376	0.0979	CbGeAlD
Bacitracin—A2M—gonad—kidney cancer	0.0358	0.0932	CbGeAlD
Bacitracin—A2M—cardiac atrium—kidney cancer	0.0358	0.0931	CbGeAlD
Bacitracin—A2M—Lipoprotein metabolism—SCARB1—kidney cancer	0.0234	0.0467	CbGpPWpGaD
Bacitracin—A2M—IL6-mediated signaling events—MITF—kidney cancer	0.0199	0.0396	CbGpPWpGaD
Bacitracin—A2M—Lipid and lipoprotein metabolism—SCARB1—kidney cancer	0.0156	0.031	CbGpPWpGaD
Bacitracin—A2M—IL6-mediated signaling events—JUNB—kidney cancer	0.0142	0.0284	CbGpPWpGaD
Bacitracin—Azotaemia—Everolimus—kidney cancer	0.0132	0.119	CcSEcCtD
Bacitracin—A2M—Rho GTPase cycle—AKAP13—kidney cancer	0.0107	0.0213	CbGpPWpGaD
Bacitracin—A2M—Degradation of the extracellular matrix—CTSB—kidney cancer	0.00986	0.0197	CbGpPWpGaD
Bacitracin—A2M—Degradation of the extracellular matrix—CTSD—kidney cancer	0.00981	0.0196	CbGpPWpGaD
Bacitracin—Azotaemia—Vincristine—kidney cancer	0.00931	0.0838	CcSEcCtD
Bacitracin—IDE—Alzheimers Disease—MAPK3—kidney cancer	0.00925	0.0184	CbGpPWpGaD
Bacitracin—IDE—Alzheimers Disease—MAPK1—kidney cancer	0.0088	0.0175	CbGpPWpGaD
Bacitracin—A2M—Platelet degranulation—IGF2—kidney cancer	0.00761	0.0152	CbGpPWpGaD
Bacitracin—IDE—Alzheimers Disease—TP53—kidney cancer	0.00739	0.0147	CbGpPWpGaD
Bacitracin—A2M—Response to elevated platelet cytosolic Ca2+—IGF2—kidney cancer	0.00725	0.0145	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—BMP7—kidney cancer	0.00602	0.012	CbGpPWpGaD
Bacitracin—A2M—IL6-mediated signaling events—JUN—kidney cancer	0.00559	0.0112	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—L1CAM—kidney cancer	0.00555	0.0111	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—ITPR2—kidney cancer	0.00549	0.0109	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.00506	0.0101	CbGpPWpGaD
Bacitracin—A2M—Degradation of the extracellular matrix—CDH1—kidney cancer	0.00451	0.00899	CbGpPWpGaD
Bacitracin—A2M—IL6-mediated signaling events—MYC—kidney cancer	0.00449	0.00896	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—ANXA2—kidney cancer	0.00421	0.00839	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—CTSB—kidney cancer	0.00413	0.00824	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—CTSD—kidney cancer	0.00411	0.0082	CbGpPWpGaD
Bacitracin—A2M—IL6-mediated signaling events—PIK3CA—kidney cancer	0.00382	0.00761	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—KCNMA1—kidney cancer	0.00349	0.00696	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—IGF2—kidney cancer	0.00338	0.00673	CbGpPWpGaD
Bacitracin—A2M—Metabolism—ACY1—kidney cancer	0.00325	0.00648	CbGpPWpGaD
Bacitracin—A2M—Platelet degranulation—VEGFA—kidney cancer	0.00319	0.00637	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—GRB7—kidney cancer	0.00304	0.00607	CbGpPWpGaD
Bacitracin—A2M—Response to elevated platelet cytosolic Ca2+—VEGFA—kidney cancer	0.00304	0.00606	CbGpPWpGaD
Bacitracin—Pain—Temsirolimus—kidney cancer	0.00288	0.0259	CcSEcCtD
Bacitracin—A2M—Hemostasis—ITPR2—kidney cancer	0.00283	0.00564	CbGpPWpGaD
Bacitracin—Albuminuria—Doxorubicin—kidney cancer	0.00279	0.0251	CcSEcCtD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.00277	0.00553	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PDHB—kidney cancer	0.00276	0.00551	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—OR4C13—kidney cancer	0.00272	0.00542	CbGpPWpGaD
Bacitracin—Pain—Pazopanib—kidney cancer	0.00271	0.0244	CcSEcCtD
Bacitracin—A2M—Metabolism—CCBL1—kidney cancer	0.0026	0.00518	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.00235	0.00468	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—LATS1—kidney cancer	0.00231	0.00461	CbGpPWpGaD
Bacitracin—A2M—Metabolism—GLIPR1—kidney cancer	0.00225	0.00449	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PPAT—kidney cancer	0.00225	0.00449	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—KDR—kidney cancer	0.00223	0.00445	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.00222	0.00443	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.0022	0.00439	CbGpPWpGaD
Bacitracin—Pain—Vinblastine—kidney cancer	0.00215	0.0194	CcSEcCtD
Bacitracin—Pain—Everolimus—kidney cancer	0.00214	0.0193	CcSEcCtD
Bacitracin—Vomiting—Temsirolimus—kidney cancer	0.00214	0.0193	CcSEcCtD
Bacitracin—Rash—Temsirolimus—kidney cancer	0.00212	0.0191	CcSEcCtD
Bacitracin—Dermatitis—Temsirolimus—kidney cancer	0.00212	0.0191	CcSEcCtD
Bacitracin—Desmopressin—PTGS1—kidney cancer	0.0021	0.636	CrCbGaD
Bacitracin—A2M—Metabolism—FH—kidney cancer	0.00209	0.00418	CbGpPWpGaD
Bacitracin—A2M—Metabolism—APRT—kidney cancer	0.00209	0.00418	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—IFNA1—kidney cancer	0.00208	0.00414	CbGpPWpGaD
Bacitracin—Pain—Erlotinib—kidney cancer	0.00207	0.0186	CcSEcCtD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.00205	0.00408	CbGpPWpGaD
Bacitracin—Vomiting—Pazopanib—kidney cancer	0.00202	0.0182	CcSEcCtD
Bacitracin—Rash—Pazopanib—kidney cancer	0.002	0.018	CcSEcCtD
Bacitracin—Nausea—Temsirolimus—kidney cancer	0.002	0.018	CcSEcCtD
Bacitracin—Dermatitis—Pazopanib—kidney cancer	0.002	0.018	CcSEcCtD
Bacitracin—A2M—Metabolism—GPC3—kidney cancer	0.00197	0.00393	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—AMER1—kidney cancer	0.00196	0.00392	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—IFNA2—kidney cancer	0.00193	0.00385	CbGpPWpGaD
Bacitracin—A2M—Metabolism—CA2—kidney cancer	0.00191	0.00382	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—CDH1—kidney cancer	0.00189	0.00377	CbGpPWpGaD
Bacitracin—Nausea—Pazopanib—kidney cancer	0.00188	0.017	CcSEcCtD
Bacitracin—A2M—Metabolism—ALAD—kidney cancer	0.00187	0.00372	CbGpPWpGaD
Bacitracin—Pain—Sorafenib—kidney cancer	0.00186	0.0167	CcSEcCtD
Bacitracin—A2M—Platelet activation, signaling and aggregation—RAF1—kidney cancer	0.00186	0.00371	CbGpPWpGaD
Bacitracin—A2M—Metabolism—ST3GAL2—kidney cancer	0.00182	0.00363	CbGpPWpGaD
Bacitracin—Pain—Sunitinib—kidney cancer	0.00179	0.0161	CcSEcCtD
Bacitracin—A2M—Metabolism—ALDH1A1—kidney cancer	0.00178	0.00355	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—IGF2—kidney cancer	0.00174	0.00347	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PGK1—kidney cancer	0.00171	0.0034	CbGpPWpGaD
Bacitracin—A2M—Metabolism—SLC5A3—kidney cancer	0.00171	0.0034	CbGpPWpGaD
Bacitracin—Pain—Dactinomycin—kidney cancer	0.00169	0.0152	CcSEcCtD
Bacitracin—A2M—Metabolism—LDHB—kidney cancer	0.00167	0.00334	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—IL2—kidney cancer	0.00167	0.00332	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—GPC3—kidney cancer	0.00165	0.00328	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CER1—kidney cancer	0.00165	0.00328	CbGpPWpGaD
Bacitracin—Vomiting—Vinblastine—kidney cancer	0.0016	0.0144	CcSEcCtD
Bacitracin—Vomiting—Everolimus—kidney cancer	0.00159	0.0143	CcSEcCtD
Bacitracin—Rash—Everolimus—kidney cancer	0.00158	0.0142	CcSEcCtD
Bacitracin—Dermatitis—Everolimus—kidney cancer	0.00158	0.0142	CcSEcCtD
Bacitracin—Vomiting—Erlotinib—kidney cancer	0.00154	0.0138	CcSEcCtD
Bacitracin—Rash—Erlotinib—kidney cancer	0.00152	0.0137	CcSEcCtD
Bacitracin—Dermatitis—Erlotinib—kidney cancer	0.00152	0.0137	CcSEcCtD
Bacitracin—Pain—Vincristine—kidney cancer	0.00151	0.0136	CcSEcCtD
Bacitracin—Nausea—Vinblastine—kidney cancer	0.00149	0.0134	CcSEcCtD
Bacitracin—Nausea—Everolimus—kidney cancer	0.00149	0.0134	CcSEcCtD
Bacitracin—A2M—Metabolism—CA9—kidney cancer	0.00145	0.00289	CbGpPWpGaD
Bacitracin—Pain—Gemcitabine—kidney cancer	0.00144	0.0129	CcSEcCtD
Bacitracin—Nausea—Erlotinib—kidney cancer	0.00144	0.0129	CcSEcCtD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	0.00142	0.00283	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	0.00142	0.00282	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—SFRP2—kidney cancer	0.0014	0.00279	CbGpPWpGaD
Bacitracin—Vomiting—Sorafenib—kidney cancer	0.00138	0.0124	CcSEcCtD
Bacitracin—Rash—Sorafenib—kidney cancer	0.00137	0.0123	CcSEcCtD
Bacitracin—Dermatitis—Sorafenib—kidney cancer	0.00137	0.0123	CcSEcCtD
Bacitracin—A2M—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	0.00134	0.00267	CbGpPWpGaD
Bacitracin—Vomiting—Sunitinib—kidney cancer	0.00133	0.012	CcSEcCtD
Bacitracin—Rash—Sunitinib—kidney cancer	0.00132	0.0119	CcSEcCtD
Bacitracin—Dermatitis—Sunitinib—kidney cancer	0.00132	0.0119	CcSEcCtD
Bacitracin—Nausea—Sorafenib—kidney cancer	0.00129	0.0116	CcSEcCtD
Bacitracin—A2M—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	0.00127	0.00254	CbGpPWpGaD
Bacitracin—Vomiting—Dactinomycin—kidney cancer	0.00126	0.0113	CcSEcCtD
Bacitracin—Rash—Dactinomycin—kidney cancer	0.00125	0.0112	CcSEcCtD
Bacitracin—Nausea—Sunitinib—kidney cancer	0.00124	0.0112	CcSEcCtD
Bacitracin—A2M—Metabolism—CRABP1—kidney cancer	0.00123	0.00246	CbGpPWpGaD
Bacitracin—Desmopressin—PTGS2—kidney cancer	0.0012	0.364	CrCbGaD
Bacitracin—Pain—Paclitaxel—kidney cancer	0.0012	0.0108	CcSEcCtD
Bacitracin—Nausea—Dactinomycin—kidney cancer	0.00118	0.0106	CcSEcCtD
Bacitracin—A2M—Metabolism—ITPR2—kidney cancer	0.00115	0.00229	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—AKAP13—kidney cancer	0.00113	0.00225	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CASP2—kidney cancer	0.00113	0.00225	CbGpPWpGaD
Bacitracin—Vomiting—Vincristine—kidney cancer	0.00112	0.0101	CcSEcCtD
Bacitracin—Rash—Vincristine—kidney cancer	0.00112	0.01	CcSEcCtD
Bacitracin—Dermatitis—Vincristine—kidney cancer	0.00111	0.01	CcSEcCtD
Bacitracin—A2M—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	0.00111	0.00221	CbGpPWpGaD
Bacitracin—Vomiting—Gemcitabine—kidney cancer	0.00107	0.00961	CcSEcCtD
Bacitracin—Rash—Gemcitabine—kidney cancer	0.00106	0.00953	CcSEcCtD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—POMC—kidney cancer	0.00106	0.00211	CbGpPWpGaD
Bacitracin—Dermatitis—Gemcitabine—kidney cancer	0.00106	0.00952	CcSEcCtD
Bacitracin—Nausea—Vincristine—kidney cancer	0.00105	0.00946	CcSEcCtD
Bacitracin—A2M—Metabolism—ACHE—kidney cancer	0.00105	0.00209	CbGpPWpGaD
Bacitracin—A2M—Metabolism—GSTT1—kidney cancer	0.00105	0.00209	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—GRB7—kidney cancer	0.00103	0.00206	CbGpPWpGaD
Bacitracin—Nausea—Gemcitabine—kidney cancer	0.000997	0.00898	CcSEcCtD
Bacitracin—A2M—Metabolism—SCARB1—kidney cancer	0.00099	0.00197	CbGpPWpGaD
Bacitracin—Pain—Capecitabine—kidney cancer	0.000986	0.00888	CcSEcCtD
Bacitracin—A2M—Metabolism—PTGS1—kidney cancer	0.00098	0.00195	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PSMD7—kidney cancer	0.000961	0.00192	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—ITPR2—kidney cancer	0.000959	0.00191	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—RAF1—kidney cancer	0.000958	0.00191	CbGpPWpGaD
Bacitracin—A2M—Metabolism—BCHE—kidney cancer	0.000911	0.00182	CbGpPWpGaD
Bacitracin—A2M—Metabolism—SLC5A5—kidney cancer	0.0009	0.0018	CbGpPWpGaD
Bacitracin—Vomiting—Paclitaxel—kidney cancer	0.000893	0.00804	CcSEcCtD
Bacitracin—Rash—Paclitaxel—kidney cancer	0.000886	0.00798	CcSEcCtD
Bacitracin—Dermatitis—Paclitaxel—kidney cancer	0.000885	0.00797	CcSEcCtD
Bacitracin—A2M—Signaling Pathways—CTNNA1—kidney cancer	0.00087	0.00173	CbGpPWpGaD
Bacitracin—A2M—Metabolism—SLC2A1—kidney cancer	0.000869	0.00173	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—EIF4EBP1—kidney cancer	0.000865	0.00172	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—HSPB1—kidney cancer	0.000865	0.00172	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—IL2—kidney cancer	0.000859	0.00171	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	0.000844	0.00168	CbGpPWpGaD
Bacitracin—Nausea—Paclitaxel—kidney cancer	0.000835	0.00751	CcSEcCtD
Bacitracin—A2M—Signaling Pathways—ANXA1—kidney cancer	0.000804	0.0016	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—TSC1—kidney cancer	0.000804	0.0016	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PSMD7—kidney cancer	0.000804	0.0016	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—FLT1—kidney cancer	0.000779	0.00155	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	0.000736	0.00147	CbGpPWpGaD
Bacitracin—Vomiting—Capecitabine—kidney cancer	0.000733	0.0066	CcSEcCtD
Bacitracin—A2M—Hemostasis—VEGFA—kidney cancer	0.00073	0.00146	CbGpPWpGaD
Bacitracin—Rash—Capecitabine—kidney cancer	0.000727	0.00655	CcSEcCtD
Bacitracin—Dermatitis—Capecitabine—kidney cancer	0.000726	0.00654	CcSEcCtD
Bacitracin—A2M—Metabolism—GSTP1—kidney cancer	0.000725	0.00145	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PAK1—kidney cancer	0.000722	0.00144	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—JUNB—kidney cancer	0.000722	0.00144	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—MAPK3—kidney cancer	0.00069	0.00138	CbGpPWpGaD
Bacitracin—A2M—Metabolism—ABCB1—kidney cancer	0.000686	0.00137	CbGpPWpGaD
Bacitracin—Nausea—Capecitabine—kidney cancer	0.000685	0.00617	CcSEcCtD
Bacitracin—A2M—Metabolism—GSTM1—kidney cancer	0.000666	0.00133	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—MAPK1—kidney cancer	0.000657	0.00131	CbGpPWpGaD
Bacitracin—Pain—Doxorubicin—kidney cancer	0.000636	0.00572	CcSEcCtD
Bacitracin—A2M—Metabolism—CYP1A1—kidney cancer	0.000632	0.00126	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—KRAS—kidney cancer	0.00062	0.00124	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—IGF2—kidney cancer	0.00059	0.00118	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CDKN2B—kidney cancer	0.000587	0.00117	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—IGF1R—kidney cancer	0.00057	0.00114	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—PIK3CA—kidney cancer	0.00057	0.00114	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—TP53—kidney cancer	0.000551	0.0011	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	0.000519	0.00103	CbGpPWpGaD
Bacitracin—Vomiting—Doxorubicin—kidney cancer	0.000473	0.00426	CcSEcCtD
Bacitracin—A2M—Metabolism—POMC—kidney cancer	0.000471	0.000939	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—HIF1A—kidney cancer	0.00047	0.000937	CbGpPWpGaD
Bacitracin—Rash—Doxorubicin—kidney cancer	0.000469	0.00422	CcSEcCtD
Bacitracin—A2M—Signaling Pathways—TSC2—kidney cancer	0.000468	0.000934	CbGpPWpGaD
Bacitracin—Dermatitis—Doxorubicin—kidney cancer	0.000468	0.00422	CcSEcCtD
Bacitracin—A2M—Signaling Pathways—KDR—kidney cancer	0.000449	0.000896	CbGpPWpGaD
Bacitracin—Nausea—Doxorubicin—kidney cancer	0.000442	0.00398	CcSEcCtD
Bacitracin—A2M—Signaling Pathways—APC—kidney cancer	0.000414	0.000825	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—KIT—kidney cancer	0.000414	0.000825	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—POMC—kidney cancer	0.000394	0.000785	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—BRAF—kidney cancer	0.000389	0.000776	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PTGS2—kidney cancer	0.000376	0.000749	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PTEN—kidney cancer	0.000328	0.000653	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—RAF1—kidney cancer	0.000325	0.000648	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—RELA—kidney cancer	0.000323	0.000645	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—ERBB2—kidney cancer	0.000321	0.000641	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—MTOR—kidney cancer	0.000317	0.000632	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CDKN1B—kidney cancer	0.000298	0.000593	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—IL2—kidney cancer	0.000291	0.000581	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CCND1—kidney cancer	0.000284	0.000566	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—JUN—kidney cancer	0.000283	0.000565	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CTNNB1—kidney cancer	0.000281	0.00056	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PTEN—kidney cancer	0.000274	0.000546	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—VEGFA—kidney cancer	0.000247	0.000493	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—MAPK3—kidney cancer	0.000234	0.000467	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PIK3CA—kidney cancer	0.000231	0.000461	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—MYC—kidney cancer	0.000228	0.000454	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—MAPK1—kidney cancer	0.000223	0.000444	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—KRAS—kidney cancer	0.00021	0.000419	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PIK3CA—kidney cancer	0.000193	0.000385	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—TP53—kidney cancer	0.000187	0.000373	CbGpPWpGaD
